Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment

NCT04634071 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation
Cancer, Treatment-Related

Interventions

DRUG: Varenicline
DRUG: Bupropion
DRUG: Long-acting nicotine replacement therapy
BEHAVIORAL: Low-intensity counseling
BEHAVIORAL: High-intensity counseling
OTHER: No nicotine replacement therapy
DRUG: Nicotine Replacement Products

Sponsor

Joseph Valentino, MD